SPX3,585.62-54.85 -1.51%
DIA287.30-4.91 -1.68%
IXIC10,575.62-161.89 -1.51%

Berenberg Downgrades Bristol-Myers Squibb to Hold, Lowers Price Target to $76

Berenberg analyst Luisa Hector downgrades Bristol-Myers Squibb (NYSE:BMY) from Buy to Hold and lowers the price target from $82 to $76.

Benzinga · 09/14/2022 04:43
Berenberg analyst Luisa Hector downgrades Bristol-Myers Squibb (NYSE:BMY) from Buy to Hold and lowers the price target from $82 to $76.